Andy Warhol, Prince, and Fair Use at the Supreme Court

Please join us on Monday, June 12, 2023 at noon for a discussion of the recent Supreme Court case Andy Warhol Foundation for the Visual Arts, Inc. v. Goldsmith (May 18, 2023) In 1981 Newsweek commissioned professional photographer Lynn Goldsmith to photograph a then “up and coming” musician named Prince Rogers Nelson, which was published [...]

By |2023-06-05T11:15:02-07:00June 3rd, 2023|Copyright, Infringement, Fair Use|0 Comments

SoCalIP Law Institute Weekly Meeting – May 8, 2023 – What My Facebook Posts Teach about Lawyer Mental Health

Please join us Monday, May 8, 2023 where we will watch a video featuring Stuart Teicher, Esq. discussing mental health issues in the legal profession.  This qualifies for one CA CLE credit for competence, and topics will include: Introduction Anxiety Stress, Burnout, and Balance Past the Breaking Points Depression & Suicide Anger Management Compassion Fatigue [...]

By |2023-05-04T14:47:57-07:00May 4th, 2023|Uncategorized|0 Comments

Software Copyright Protection and Drama Surrounding Judge Newman

It's Becoming Harder and Harder to Protect Software Function with Copyright In SAS Institute, Inc. v. World Programming Limited, Case No. 2021-1542 (Fed. Cir. April 6, 2023) (opinion here), the general question raise is as to the scope of protection afforded to computer software and computer software function specifically. SAS offers a software product called the [...]

By |2023-04-16T17:18:35-07:00April 16th, 2023|copyrightability, Copyright|0 Comments

9th Circuit sides with GoDaddy in Cybersquatting/Lanham Act Case: Rigsby v. GoDaddy

On Monday, April 9, 2023, Marina Lang will lead the discussion about recent 9th Circuit Opinion RIGSBY V. GODADDY INC. See Published Opinion Here: The panel held that Plaintiff--a well known athlete and speaker-- could not satisfy “use in commerce” prong of the Lanham Act & could not overcome GoDaddy’s immunity protections under the [...]

By |2023-04-09T12:58:16-07:00April 9th, 2023|Trademark|0 Comments

Jack Daniel’s is Not Amused by Bad Spaniels Chew Toy; Publishers Awarded Summary Judgment Against Internet Archive

Jack Daniel’s is Not Amused by Bad Spaniels Chew Toy; Publishers Awarded Summary Judgment Against Internet Archive On Monday, April 3, 2023, Chris Kopitzke will lead the discussion about a pending Supreme Court trademark case concerning a dog chew toy, as well as a recent copyright decision out of the Southern District of New York [...]

By |2023-04-02T10:11:17-07:00April 2nd, 2023|Trademark|0 Comments

Remedies for Patent, Trademark, and Copyright Infringementi

Remedies for Patent, Trademark, and Copyright Infringement Patent The remedy statute for patent infringement states, “Upon finding for the claimant the court shall award the claimant damages adequate to compensate for the infringement, but in no event less than a reasonable royalty for the use made of the invention by the infringer, together with interest [...]

By |2023-03-15T09:42:11-07:00March 14th, 2023|Copyright, Patent, Trademark, Counterfeit, Damages|0 Comments

SoCal IP Law Institute MCLE meeting of March 13, 2023 – CAFC regarding written description and section 101.

Please join us on Monday, March 13, 2023 at Noon , where we will discuss two CAFC decision for Patents: one re: Written Description requirements and the other re: Patentable Subject Matter under Section 101. For CAFC Written Description requirements, please see: University of Minnesota v. Gilead Sciences at 21-2168.OPINION.3-6-2023_2090143. For CAFC re: Patentable Subject [...]

SoCalIP Law Institute Weekly Meeting – March 6, 2023 – Rx patent monopoly and Lizzo TM win

Please join us Monday, March 6, 2023 where we will discuss Rx patent monopoly issues and Lizzo's TM win.  Specific case discussions will include: AbbVie Rx Patent Monopoly Strategy Against Biosimilars - AbbVie makes Humera for arthritis and extended its monopoly for 7 years past the 2016 expiration date of its basic patent on the [...]

By |2023-03-02T12:51:55-08:00March 2nd, 2023|TTAB, monopoly, Antitrust, FDA, Patent, Trademark|0 Comments
Go to Top